eClinical Technology and Industy News

Iterative Scopes and Crohn’s & Colitis Foundation Announce Partnership to Advance Next-Generation IBD Treatment

Access to the Foundation’s unparalleled patient data repository will enrich company’s computational endoscopic approaches to biopharmaceutical research and clinical care for IBD

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Iterative Scopes, a pioneer in the development of precision-based technologies for treating gastrointestinal diseases, announced today that it has entered into an AI-powered diagnostic tools partnership with the Crohns & Colitis Foundation (the Foundation), the leading patient organization dedicated to improving the quality of life of those affected by inflammatory bowel disease (IBD). A major goal of the relationship is to incorporate the Foundation’s comprehensive repository of data on the patient journey into the company’s next-generation endoscopic tools that have the potential to improve the care of IBD patients worldwide.

The partnership gives Iterative Scopes rights to access IBD Plexus®, the Foundation’s first-of-its-kind research information exchange platform, for the purpose of delivering artificial intelligence-driven endoscopic solutions to life sciences researchers and healthcare providers. IBD Plexus is a groundbreaking initiative that provides the IBD research community with analysis-ready datasets and biosamples, offering longitudinal, clinical, genetic, biosignature, and patient experience data from a broad network of sources.

Iterative Scopes intends to collect imaging data from sites participating in IBD Plexus research initiatives to inform its computational models of disease severity scoring algorithms and to further advance its precision medicine initiatives. The results of this work will be eventually integrated with IBD Plexus rich, multi-dimensional data to enable deeper understanding of the full patient journey, which is a key component of the company’s efforts to better predict individual disease progression.

Click the button below to read the entire Press Release:

Continue Reading The Press Release

Discover What Sets TrialStat Apart From Ordinary EDC Platforms

Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?